2.5TWD
294.72 MTWD
1.20 BTWD
74.57 M
About SCI PHARMTECH INC
Sector
CEO
Wei Chun Weng
Headquarters
Taoyuan
Website
Founded
1987
ISIN
TW0004119003
FIGI
BBG000NXBKN9
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. It focuses in the research, development, process, manufacture and sale of active pharmaceutical ingredient (API), API intermediates, and special and precision chemicals. The company's products are used for anti-epilepsy, anticonvulsant, sleeping pills, anesthesia, arrhythmia, antibiotics, anti-anorexia agents, smoking cessation drug, hypertension, antiparkinsonian, diet pills, anti-AIDS, steroid, and antidepressant. SCI Pharmtech was founded on September 18, 1987 and is headquartered in Taoyuan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4119 is 86.4 TWD — it has decreased by 2.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SCI PHARMTECH INC stocks are traded under the ticker 4119.
SCI PHARMTECH INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
4119 stock is 3.15% volatile and has beta coefficient of −0.27. Check out the list of the most volatile stocks — is SCI PHARMTECH INC there?
4119 earnings for the last quarter are 1.74 TWD per share, whereas the estimation was 1.76 TWD resulting in a −1.24% surprise. The estimated earnings for the next quarter are 1.83 TWD per share. See more details about SCI PHARMTECH INC earnings.
SCI PHARMTECH INC revenue for the last quarter amounts to 679.00 M TWD despite the estimated figure of 678.50 M TWD. In the next quarter revenue is expected to reach 286.00 M TWD.
Yes, you can track SCI PHARMTECH INC financials in yearly and quarterly reports right on TradingView.
4119 stock has fallen by 2.59% compared to the previous week, the month change is a 1.59% fall, over the last year SCI PHARMTECH INC has showed a 25.76% decrease.
4119 net income for the last quarter is −3.61 M TWD, while the quarter before that showed 35.38 M TWD of net income which accounts for −110.21% change. Track more SCI PHARMTECH INC financial stats to get the full picture.
Today SCI PHARMTECH INC has the market capitalization of 10.55 B, it has decreased by 0.68% over the last week.
Yes, 4119 dividends are paid annually. The last dividend per share was 0.25 TWD. As of today, Dividend Yield (TTM)% is 0.25%. Tracking SCI PHARMTECH INC dividends might help you take more informed decisions.
SCI PHARMTECH INC dividend yield was 1.29% in 2023, and payout ratio reached 46.36%. The year before the numbers were 0.26% and 7.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4119 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCI PHARMTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SCI PHARMTECH INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SCI PHARMTECH INC stock shows the neutral signal. See more of SCI PHARMTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCI PHARMTECH INC EBITDA is 305.59 M TWD, and current EBITDA margin is 25.38%. See more stats in SCI PHARMTECH INC financial statements.